These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 11891322)

  • 1. Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts.
    Berg T; Cohen SB; Desharnais J; Sonderegger C; Maslyar DJ; Goldberg J; Boger DL; Vogt PK
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3830-5. PubMed ID: 11891322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low molecular weight inhibitors of Myc-Max interaction and function.
    Yin X; Giap C; Lazo JS; Prochownik EV
    Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure, function, and dynamics of the dimerization and DNA-binding domain of oncogenic transcription factor v-Myc.
    Fieber W; Schneider ML; Matt T; Kräutler B; Konrat R; Bister K
    J Mol Biol; 2001 Apr; 307(5):1395-410. PubMed ID: 11292350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A credit-card library approach for disrupting protein-protein interactions.
    Xu Y; Shi J; Yamamoto N; Moss JA; Vogt PK; Janda KD
    Bioorg Med Chem; 2006 Apr; 14(8):2660-73. PubMed ID: 16384710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of c-Myc/Max dimerization and DNA binding by small molecules.
    Kiessling A; Sperl B; Hollis A; Eick D; Berg T
    Chem Biol; 2006 Jul; 13(7):745-51. PubMed ID: 16873022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
    Gupta K; Anand G; Yin X; Grove L; Prochownik EV
    Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the Myc and Max interaction specificity with lambda repressor-HLH domain fusions.
    Marchetti A; Abril-Marti M; Illi B; Cesareni G; Nasi S
    J Mol Biol; 1995 May; 248(3):541-50. PubMed ID: 7752223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of Max: role of basic, helix-loop-helix/leucine zipper domains in DNA binding, dimerization and regulation of Myc-mediated transcriptional activation.
    Reddy CD; Dasgupta P; Saikumar P; Dudek H; Rauscher FJ; Reddy EP
    Oncogene; 1992 Oct; 7(10):2085-92. PubMed ID: 1408152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of sequences responsible for the differential regulation of Myc function by delta Max and Max.
    Västrik I; Mäkelä TP; Koskinen PJ; Alitalo K
    Oncogene; 1995 Aug; 11(3):553-60. PubMed ID: 7630640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both the helix-loop-helix and the leucine zipper motifs of c-Myc contribute to its dimerization specificity with Max.
    Davis LJ; Halazonetis TD
    Oncogene; 1993 Jan; 8(1):125-32. PubMed ID: 8423990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Function of the c-Myc oncogenic transcription factor.
    Dang CV; Resar LM; Emison E; Kim S; Li Q; Prescott JE; Wonsey D; Zeller K
    Exp Cell Res; 1999 Nov; 253(1):63-77. PubMed ID: 10579912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic activity of the c-Myc protein requires dimerization with Max.
    Amati B; Brooks MW; Levy N; Littlewood TD; Evan GI; Land H
    Cell; 1993 Jan; 72(2):233-45. PubMed ID: 8425220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of the MYC transcriptional function by a small-molecule antagonist of MYC/MAX dimerization.
    Lu X; Vogt PK; Boger DL; Lunec J
    Oncol Rep; 2008 Mar; 19(3):825-30. PubMed ID: 18288422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and properties of a Myc derivative that efficiently homodimerizes.
    Soucek L; Helmer-Citterich M; Sacco A; Jucker R; Cesareni G; Nasi S
    Oncogene; 1998 Nov; 17(19):2463-72. PubMed ID: 9824157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stabilizers of the Max homodimer identified in virtual ligand screening inhibit Myc function.
    Jiang H; Bower KE; Beuscher AE; Zhou B; Bobkov AA; Olson AJ; Vogt PK
    Mol Pharmacol; 2009 Sep; 76(3):491-502. PubMed ID: 19498040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small-molecule modulators of c-Myc/Max and Max/Max interactions.
    Berg T
    Curr Top Microbiol Immunol; 2011; 348():139-49. PubMed ID: 20680803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA binding and transcriptional activation in yeast correlates with transforming capacity.
    Crouch DH; Fisher F; Clark W; Jayaraman PS; Goding CR; Gillespie DA
    Oncogene; 1993 Jul; 8(7):1849-55. PubMed ID: 8510929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative forms of Max as enhancers or suppressors of Myc-ras cotransformation.
    Mäkelä TP; Koskinen PJ; Västrik I; Alitalo K
    Science; 1992 Apr; 256(5055):373-7. PubMed ID: 1566084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecule inhibitors of Myc/Max dimerization and Myc-induced cell transformation.
    Shi J; Stover JS; Whitby LR; Vogt PK; Boger DL
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6038-41. PubMed ID: 19800226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif.
    Hurlin PJ; Steingrìmsson E; Copeland NG; Jenkins NA; Eisenman RN
    EMBO J; 1999 Dec; 18(24):7019-28. PubMed ID: 10601024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.